A detailed history of Gate Pass Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Gate Pass Capital, LLC holds 49,016 shares of PFE stock, worth $1.21 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
49,016
Previous 48,908 0.22%
Holding current value
$1.21 Million
Previous $1.19 Billion 5.35%
% of portfolio
0.72%
Previous 0.79%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025

BUY
$23.29 - $25.88 $2,515 - $2,795
108 Added 0.22%
49,016 $1.25 Billion
Q2 2025

Sep 22, 2025

SELL
$21.59 - $24.84 $364,525 - $419,398
-16,884 Reduced 25.66%
48,908 $1.19 Billion
Q1 2025

Sep 22, 2025

BUY
$25.01 - $27.13 $520,007 - $564,086
20,792 Added 46.2%
65,792 $1.67 Billion
Q4 2024

Sep 22, 2025

BUY
$24.8 - $30.19 $1.12 Million - $1.36 Million
45,000 New
45,000 $1.19 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $138B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Gate Pass Capital, LLC Portfolio

Follow Gate Pass Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gate Pass Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gate Pass Capital, LLC with notifications on news.